scispace - formally typeset
W

Wenshu Li

Researcher at Centers for Disease Control and Prevention

Publications -  10
Citations -  517

Wenshu Li is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Sierra leone & Ebola virus. The author has an hindex of 8, co-authored 9 publications receiving 356 citations.

Papers
More filters
Journal ArticleDOI

Impact of Ebola experiences and risk perceptions on mental health in Sierra Leone, July 2015

TL;DR: Symptoms of PTSD and anxiety-depression were common after one year of Ebola response; psychosocial support may be needed for people with Ebola-related experiences.
Journal ArticleDOI

National survey of Ebola-related knowledge, attitudes and practices before the outbreak peak in Sierra Leone: August 2014

TL;DR: There was high awareness of the disease but misconceptions and discriminatory attitudes toward survivors remained common three months into the 2014 Ebola outbreak in Sierra Leone, suggesting the importance of KAP assessment early in an epidemic.
Journal ArticleDOI

Risk Communication and Ebola-Specific Knowledge and Behavior during 2014–2015 Outbreak, Sierra Leone

TL;DR: Knowledge and protective behavior were associated with the outbreak level, most strongly after the peak, whereas risk behavior was seen at all levels of the outbreak.
Journal ArticleDOI

Knowledge, Attitudes, and Practices Related to Ebola Virus Disease at the End of a National Epidemic — Guinea, August 2015

TL;DR: Ebola KAP were assessed in a survey among residents of Guinea recruited through multistage cluster sampling procedures in the nation's eight administrative regions to prevent and respond to future outbreaks or sporadic cases of Ebola.
Journal ArticleDOI

Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey.

TL;DR: The high acceptability of hypothetical vaccines indicates strong potential for introducing Ebola vaccines across Guinea and strategies to build public confidence in use of Ebola vaccines should highlight any similarities with safe, effective vaccines routinely used in Guinea.